Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Frontiers in Microbiology|September 5, 2022
Folic acid restricts SARS-CoV-2 invasion by methylating ACE2Yuanzhou Zhang, Yechun Pang, Baiyin Xu, et al.
International Journal of Biological Macromolecules|July 13, 2023
Engineered multitargeting exosomes carrying miR-323a-3p for CRC therapyYechun Pang, Xingshi Chen, Baiying Xu, et al.
Cell Death & Disease|March 23, 2022
MiR-323a regulates ErbB3/EGFR and blocks gefitinib resistance acquisition in colorectal cancerYuanzhou Zhang, Shunshun Liang, Bowen Xiao, et al.
Nature Communications|August 22, 2024
Sintilimab in combination with stereotactic body radiotherapy and granulocyte-macrophage colony-stimulating factor in metastatic non-small cell lung cancer: The multicenter SWORD phase 2 trialJianjiao Ni, Xiaofei Wang, Lin Wu, et al.
Experimental Hematology & Oncology|December 19, 2024
Identification of a novel subtype of SPP1 + macrophages expressing SIRPα: implications for tumor immune evasion and treatment response predictionKun Chen, Yida Li, Jianjiao Ni, et al.
Clinical and Translational Medicine|September 26, 2025
Radiation-induced extracellular vesicles from cancer-associated fibroblasts drive oesophageal squamous cell carcinoma metastasis via the miR-193a-3p/PTEN/Akt pathwayYechun Pang, Tiantian Guo, Yue Zhou, et al.
Translational Lung Cancer Research|May 22, 2026
Cadonilimab induction and consolidation for unresectable stage III non-small cell lung cancer patients receiving concurrent chemoradiation: safety run-in results of a prospective, phase II trialJianjiao Ni, Zilu Zheng, Xi Yang, et al.
Cancer Immunology, Immunotherapy : CII|June 4, 2024
Prognostic value of genomic mutation signature associated with immune microenvironment in southern Chinese patients with esophageal squamous cell carcinomaYue Zhou, Li Chu, Shuyan Li, et al.
Cancer Immunology, Immunotherapy : CII|March 19, 2025
Early local therapy in combination with PD-1/PD-L1 inhibitors in oligometastatic non-small cell lung cancer: results from a prospective multicenter observational studyJie Gao, Aihua Lan, Xi Yang, et al.
Plos Medicine|August 1, 2025
Consolidative stereotactic radiotherapy for oligo-residual non-small cell lung cancer after first-line chemoimmunotherapy: A single-arm, phase 2 trial from ChinaHongru Chen, Lu Yu, Fei Liang, et al.
Pageof 2